nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00417	0.248	CbGbCtD
Indapamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.00316	0.188	CbGbCtD
Indapamide—CYP3A4—Betamethasone—psoriatic arthritis	0.00271	0.161	CbGbCtD
Indapamide—CYP3A4—Prednisolone—psoriatic arthritis	0.00267	0.159	CbGbCtD
Indapamide—CYP3A4—Prednisone—psoriatic arthritis	0.00253	0.15	CbGbCtD
Indapamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00158	0.0937	CbGbCtD
Indapamide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Indapamide—Malaise—Dexamethasone—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Indapamide—Malaise—Betamethasone—psoriatic arthritis	0.00113	0.00115	CcSEcCtD
Indapamide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Oedema—Triamcinolone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Vertigo—Dexamethasone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Vertigo—Betamethasone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Syncope—Dexamethasone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Syncope—Betamethasone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Arrhythmia—Prednisone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Infection—Triamcinolone—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Sweating—Methotrexate—psoriatic arthritis	0.00112	0.00114	CcSEcCtD
Indapamide—Infection—Methylprednisolone—psoriatic arthritis	0.00111	0.00113	CcSEcCtD
Indapamide—Shock—Triamcinolone—psoriatic arthritis	0.00111	0.00113	CcSEcCtD
Indapamide—Insomnia—Prednisolone—psoriatic arthritis	0.00111	0.00113	CcSEcCtD
Indapamide—Shock—Methylprednisolone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Tachycardia—Triamcinolone—psoriatic arthritis	0.0011	0.00112	CcSEcCtD
Indapamide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.0011	0.00111	CcSEcCtD
Indapamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Indapamide—Erythema—Prednisone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Indapamide—Malnutrition—Prednisone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Indapamide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00109	0.00111	CcSEcCtD
Indapamide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00108	0.0011	CcSEcCtD
Indapamide—Myalgia—Betamethasone—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Indapamide—Myalgia—Dexamethasone—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Indapamide—Anxiety—Betamethasone—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Indapamide—Anxiety—Dexamethasone—psoriatic arthritis	0.00106	0.00108	CcSEcCtD
Indapamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Indapamide—Discomfort—Betamethasone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Indapamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00105	0.00107	CcSEcCtD
Indapamide—Pain—Prednisolone—psoriatic arthritis	0.00105	0.00106	CcSEcCtD
Indapamide—Hepatitis—Methotrexate—psoriatic arthritis	0.00105	0.00106	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00104	0.00106	CcSEcCtD
Indapamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00103	0.00105	CcSEcCtD
Indapamide—Vision blurred—Prednisone—psoriatic arthritis	0.00103	0.00104	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Oedema—Betamethasone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Oedema—Dexamethasone—psoriatic arthritis	0.00102	0.00104	CcSEcCtD
Indapamide—Insomnia—Triamcinolone—psoriatic arthritis	0.00102	0.00103	CcSEcCtD
Indapamide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00102	0.00103	CcSEcCtD
Indapamide—Infection—Dexamethasone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Infection—Betamethasone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00101	0.00103	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—psoriatic arthritis	0.00101	0.00102	CcSEcCtD
Indapamide—Anaemia—Prednisone—psoriatic arthritis	0.00101	0.00102	CcSEcCtD
Indapamide—Shock—Dexamethasone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Shock—Betamethasone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Agitation—Prednisone—psoriatic arthritis	0.001	0.00102	CcSEcCtD
Indapamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000999	0.00102	CcSEcCtD
Indapamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000999	0.00102	CcSEcCtD
Indapamide—Tachycardia—Dexamethasone—psoriatic arthritis	0.000996	0.00101	CcSEcCtD
Indapamide—Tachycardia—Betamethasone—psoriatic arthritis	0.000996	0.00101	CcSEcCtD
Indapamide—Angioedema—Prednisone—psoriatic arthritis	0.000995	0.00101	CcSEcCtD
Indapamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00099	0.00101	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000989	0.00101	CcSEcCtD
Indapamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000988	0.001	CcSEcCtD
Indapamide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000987	0.001	CcSEcCtD
Indapamide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000987	0.001	CcSEcCtD
Indapamide—Malaise—Prednisone—psoriatic arthritis	0.000982	0.000999	CcSEcCtD
Indapamide—Vertigo—Prednisone—psoriatic arthritis	0.000978	0.000995	CcSEcCtD
Indapamide—Syncope—Prednisone—psoriatic arthritis	0.000977	0.000993	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—psoriatic arthritis	0.000975	0.000991	CcSEcCtD
Indapamide—Anorexia—Dexamethasone—psoriatic arthritis	0.000973	0.000989	CcSEcCtD
Indapamide—Anorexia—Betamethasone—psoriatic arthritis	0.000973	0.000989	CcSEcCtD
Indapamide—Urticaria—Prednisolone—psoriatic arthritis	0.000972	0.000988	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00097	0.000987	CcSEcCtD
Indapamide—Fatigue—Triamcinolone—psoriatic arthritis	0.00097	0.000986	CcSEcCtD
Indapamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000968	0.000984	CcSEcCtD
Indapamide—Pain—Triamcinolone—psoriatic arthritis	0.000962	0.000978	CcSEcCtD
Indapamide—Loss of consciousness—Prednisone—psoriatic arthritis	0.000957	0.000974	CcSEcCtD
Indapamide—Hypotension—Betamethasone—psoriatic arthritis	0.000954	0.00097	CcSEcCtD
Indapamide—Hypotension—Dexamethasone—psoriatic arthritis	0.000954	0.00097	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00093	0.000946	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00093	0.000946	CcSEcCtD
Indapamide—Arthralgia—Prednisone—psoriatic arthritis	0.000927	0.000943	CcSEcCtD
Indapamide—Myalgia—Prednisone—psoriatic arthritis	0.000927	0.000943	CcSEcCtD
Indapamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000927	0.000943	CcSEcCtD
Indapamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000925	0.000941	CcSEcCtD
Indapamide—Anxiety—Prednisone—psoriatic arthritis	0.000924	0.00094	CcSEcCtD
Indapamide—Insomnia—Dexamethasone—psoriatic arthritis	0.000923	0.000939	CcSEcCtD
Indapamide—Insomnia—Betamethasone—psoriatic arthritis	0.000923	0.000939	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000921	0.000937	CcSEcCtD
Indapamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000918	0.000933	CcSEcCtD
Indapamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000916	0.000932	CcSEcCtD
Indapamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000916	0.000932	CcSEcCtD
Indapamide—Discomfort—Prednisone—psoriatic arthritis	0.000916	0.000932	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—psoriatic arthritis	0.00091	0.000926	CcSEcCtD
Indapamide—Erythema—Methotrexate—psoriatic arthritis	0.00091	0.000926	CcSEcCtD
Indapamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000901	0.000917	CcSEcCtD
Indapamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000898	0.000914	CcSEcCtD
Indapamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000898	0.000914	CcSEcCtD
Indapamide—Urticaria—Triamcinolone—psoriatic arthritis	0.000894	0.000909	CcSEcCtD
Indapamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000892	0.000907	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000891	0.000907	CcSEcCtD
Indapamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000889	0.000904	CcSEcCtD
Indapamide—Oedema—Prednisone—psoriatic arthritis	0.000889	0.000904	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000889	0.000904	CcSEcCtD
Indapamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000887	0.000902	CcSEcCtD
Indapamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000887	0.000902	CcSEcCtD
Indapamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000887	0.000902	CcSEcCtD
Indapamide—Infection—Prednisone—psoriatic arthritis	0.000883	0.000898	CcSEcCtD
Indapamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000881	0.000896	CcSEcCtD
Indapamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000881	0.000896	CcSEcCtD
Indapamide—Back pain—Methotrexate—psoriatic arthritis	0.00088	0.000895	CcSEcCtD
Indapamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00088	0.000895	CcSEcCtD
Indapamide—Fatigue—Betamethasone—psoriatic arthritis	0.00088	0.000895	CcSEcCtD
Indapamide—Shock—Prednisone—psoriatic arthritis	0.000874	0.000889	CcSEcCtD
Indapamide—Pain—Dexamethasone—psoriatic arthritis	0.000873	0.000888	CcSEcCtD
Indapamide—Pain—Betamethasone—psoriatic arthritis	0.000873	0.000888	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000872	0.000887	CcSEcCtD
Indapamide—Tachycardia—Prednisone—psoriatic arthritis	0.000867	0.000882	CcSEcCtD
Indapamide—Skin disorder—Prednisone—psoriatic arthritis	0.000863	0.000878	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000859	0.000874	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—psoriatic arthritis	0.000858	0.000872	CcSEcCtD
Indapamide—Anorexia—Prednisone—psoriatic arthritis	0.000847	0.000862	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000844	0.000859	CcSEcCtD
Indapamide—Anaemia—Methotrexate—psoriatic arthritis	0.000841	0.000856	CcSEcCtD
Indapamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000841	0.000855	CcSEcCtD
Indapamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000841	0.000855	CcSEcCtD
Indapamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000835	0.000849	CcSEcCtD
Indapamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000835	0.000849	CcSEcCtD
Indapamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000829	0.000843	CcSEcCtD
Indapamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000827	0.000841	CcSEcCtD
Indapamide—Malaise—Methotrexate—psoriatic arthritis	0.000821	0.000835	CcSEcCtD
Indapamide—Vertigo—Methotrexate—psoriatic arthritis	0.000818	0.000832	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—psoriatic arthritis	0.000815	0.000829	CcSEcCtD
Indapamide—Urticaria—Betamethasone—psoriatic arthritis	0.000811	0.000825	CcSEcCtD
Indapamide—Urticaria—Dexamethasone—psoriatic arthritis	0.000811	0.000825	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00081	0.000824	CcSEcCtD
Indapamide—Dizziness—Prednisolone—psoriatic arthritis	0.000809	0.000823	CcSEcCtD
Indapamide—Asthenia—Triamcinolone—psoriatic arthritis	0.000807	0.000821	CcSEcCtD
Indapamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000807	0.000821	CcSEcCtD
Indapamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000807	0.000821	CcSEcCtD
Indapamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000807	0.000821	CcSEcCtD
Indapamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000807	0.000821	CcSEcCtD
Indapamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000805	0.000819	CcSEcCtD
Indapamide—Insomnia—Prednisone—psoriatic arthritis	0.000804	0.000818	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—psoriatic arthritis	0.000798	0.000812	CcSEcCtD
Indapamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000796	0.000809	CcSEcCtD
Indapamide—Cough—Methotrexate—psoriatic arthritis	0.000794	0.000808	CcSEcCtD
Indapamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000794	0.000808	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—psoriatic arthritis	0.000782	0.000796	CcSEcCtD
Indapamide—Chest pain—Methotrexate—psoriatic arthritis	0.000775	0.000788	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—psoriatic arthritis	0.000775	0.000788	CcSEcCtD
Indapamide—Myalgia—Methotrexate—psoriatic arthritis	0.000775	0.000788	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—psoriatic arthritis	0.000773	0.000786	CcSEcCtD
Indapamide—Rash—Prednisolone—psoriatic arthritis	0.000771	0.000784	CcSEcCtD
Indapamide—Dermatitis—Prednisolone—psoriatic arthritis	0.00077	0.000784	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00077	0.000783	CcSEcCtD
Indapamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000768	0.000781	CcSEcCtD
Indapamide—Fatigue—Prednisone—psoriatic arthritis	0.000766	0.000779	CcSEcCtD
Indapamide—Headache—Prednisolone—psoriatic arthritis	0.000766	0.000779	CcSEcCtD
Indapamide—Discomfort—Methotrexate—psoriatic arthritis	0.000766	0.000779	CcSEcCtD
Indapamide—Constipation—Prednisone—psoriatic arthritis	0.00076	0.000773	CcSEcCtD
Indapamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000744	0.000757	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000743	0.000756	CcSEcCtD
Indapamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000742	0.000755	CcSEcCtD
Indapamide—Infection—Methotrexate—psoriatic arthritis	0.000738	0.000751	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000732	0.000745	CcSEcCtD
Indapamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000732	0.000745	CcSEcCtD
Indapamide—Asthenia—Betamethasone—psoriatic arthritis	0.000732	0.000745	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000728	0.000741	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000727	0.00074	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000727	0.000739	CcSEcCtD
Indapamide—Nausea—Prednisolone—psoriatic arthritis	0.000727	0.000739	CcSEcCtD
Indapamide—Pruritus—Betamethasone—psoriatic arthritis	0.000722	0.000734	CcSEcCtD
Indapamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000722	0.000734	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—psoriatic arthritis	0.000722	0.000734	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000718	0.00073	CcSEcCtD
Indapamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000715	0.000727	CcSEcCtD
Indapamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000714	0.000726	CcSEcCtD
Indapamide—Rash—Triamcinolone—psoriatic arthritis	0.000709	0.000721	CcSEcCtD
Indapamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000709	0.000721	CcSEcCtD
Indapamide—Anorexia—Methotrexate—psoriatic arthritis	0.000708	0.00072	CcSEcCtD
Indapamide—Rash—Methylprednisolone—psoriatic arthritis	0.000708	0.00072	CcSEcCtD
Indapamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000707	0.000719	CcSEcCtD
Indapamide—Urticaria—Prednisone—psoriatic arthritis	0.000706	0.000718	CcSEcCtD
Indapamide—Headache—Triamcinolone—psoriatic arthritis	0.000705	0.000717	CcSEcCtD
Indapamide—Headache—Methylprednisolone—psoriatic arthritis	0.000703	0.000715	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—psoriatic arthritis	0.000703	0.000715	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—psoriatic arthritis	0.000703	0.000715	CcSEcCtD
Indapamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000698	0.00071	CcSEcCtD
Indapamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000698	0.00071	CcSEcCtD
Indapamide—Hypotension—Methotrexate—psoriatic arthritis	0.000694	0.000706	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000677	0.000688	CcSEcCtD
Indapamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000675	0.000686	CcSEcCtD
Indapamide—Dizziness—Betamethasone—psoriatic arthritis	0.000675	0.000686	CcSEcCtD
Indapamide—Insomnia—Methotrexate—psoriatic arthritis	0.000672	0.000683	CcSEcCtD
Indapamide—Nausea—Triamcinolone—psoriatic arthritis	0.000668	0.00068	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000667	0.000678	CcSEcCtD
Indapamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000667	0.000678	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000662	0.000674	CcSEcCtD
Indapamide—Somnolence—Methotrexate—psoriatic arthritis	0.00066	0.000672	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000655	0.000666	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000654	0.000665	CcSEcCtD
Indapamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000649	0.00066	CcSEcCtD
Indapamide—Vomiting—Betamethasone—psoriatic arthritis	0.000649	0.00066	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000646	0.000657	CcSEcCtD
Indapamide—Rash—Betamethasone—psoriatic arthritis	0.000644	0.000655	CcSEcCtD
Indapamide—Rash—Dexamethasone—psoriatic arthritis	0.000644	0.000655	CcSEcCtD
Indapamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000643	0.000654	CcSEcCtD
Indapamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000643	0.000654	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000641	0.000652	CcSEcCtD
Indapamide—Fatigue—Methotrexate—psoriatic arthritis	0.00064	0.000651	CcSEcCtD
Indapamide—Headache—Dexamethasone—psoriatic arthritis	0.000639	0.00065	CcSEcCtD
Indapamide—Headache—Betamethasone—psoriatic arthritis	0.000639	0.00065	CcSEcCtD
Indapamide—Asthenia—Prednisone—psoriatic arthritis	0.000638	0.000649	CcSEcCtD
Indapamide—Pain—Methotrexate—psoriatic arthritis	0.000635	0.000646	CcSEcCtD
Indapamide—Pruritus—Prednisone—psoriatic arthritis	0.000629	0.00064	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000612	0.000623	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000608	0.000619	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000607	0.000618	CcSEcCtD
Indapamide—Nausea—Dexamethasone—psoriatic arthritis	0.000606	0.000617	CcSEcCtD
Indapamide—Nausea—Betamethasone—psoriatic arthritis	0.000606	0.000617	CcSEcCtD
Indapamide—Urticaria—Methotrexate—psoriatic arthritis	0.00059	0.0006	CcSEcCtD
Indapamide—Dizziness—Prednisone—psoriatic arthritis	0.000588	0.000598	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000587	0.000597	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000587	0.000597	CcSEcCtD
Indapamide—Vomiting—Prednisone—psoriatic arthritis	0.000565	0.000575	CcSEcCtD
Indapamide—Rash—Prednisone—psoriatic arthritis	0.00056	0.00057	CcSEcCtD
Indapamide—Dermatitis—Prednisone—psoriatic arthritis	0.00056	0.000569	CcSEcCtD
Indapamide—Headache—Prednisone—psoriatic arthritis	0.000557	0.000566	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000547	0.000557	CcSEcCtD
Indapamide—Asthenia—Methotrexate—psoriatic arthritis	0.000533	0.000542	CcSEcCtD
Indapamide—Nausea—Prednisone—psoriatic arthritis	0.000528	0.000537	CcSEcCtD
Indapamide—Pruritus—Methotrexate—psoriatic arthritis	0.000526	0.000535	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000508	0.000517	CcSEcCtD
Indapamide—Dizziness—Methotrexate—psoriatic arthritis	0.000491	0.0005	CcSEcCtD
Indapamide—Vomiting—Methotrexate—psoriatic arthritis	0.000472	0.00048	CcSEcCtD
Indapamide—Rash—Methotrexate—psoriatic arthritis	0.000468	0.000476	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—psoriatic arthritis	0.000468	0.000476	CcSEcCtD
Indapamide—Headache—Methotrexate—psoriatic arthritis	0.000465	0.000473	CcSEcCtD
Indapamide—Nausea—Methotrexate—psoriatic arthritis	0.000441	0.000449	CcSEcCtD
